Immune Cell Therapy: The main trend in tumor treatment, a new generation of tumor treatment methods

Immune cell therapy technology involves collecting a small amount of venous blood from a tumor patient, isolating mononuclear cells in a GMP cell laboratory, and adding a series of cytokines for induction, enabling the immune cells to recognize tumor cells while increasing their number by over 1000 times and enhancing their bactericidal capacity. Then, the active immune cells with anti-tumor effects are reinfused into the patient via infusion, directly killing tumor cells. Research shows that immune cell therapy technology kills tumor cells without harming the normal body, has very few side effects, and can effectively regulate and enhance the patient’s immunity, prevent tumor recurrence and metastasis. Early-stage tumor patients using immune cell therapy technology have a higher 5-year survival rate.

Common, most mature and effective immune cell therapy technologies include NK cells, DC cells, CIK cells, DC-CIK cells, CEA-rV-DC-CIK cells, AAV-DC-CIK cell technology, etc.